Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
"Prime demonstrated how actual patients saved on prescription drugs as a result of the agreement [between Prime and Express Scripts, Inc. ('ESI')]. With this ruling, AHF is seeking to rewind the clock ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The cost of Cole Schmidtknecht’s asthma inhaler was raised to over $500. His parents said Cole chose rent over medicine. Days ...
1don MSNOpinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...
La., said the Senate Health, Education, Labor and Pensions Committee should also increase gig worker access to portable ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback